Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Adv Exp Med Biol ; 977: 15-20, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28685422

RESUMEN

Modern medical practice has resulted in the accumulation of a growing number of incurable chronic diseases, many of which are inflammatory in nature. Inflammation establishes a hypoxic microenvironment within tissues, a condition of inflammatory hypoxia (IH). Tissues thus affected become severely compromised, are unable to elicit adaptive responses and eventually develop fibrosis and fixed microvascular deficits. Previous work has demonstrated that tissue hypoxia exits even within the simple human model of self-resolving inflammation, the tuberculin reaction. Failed resolution of IH establishes a vicious cycle within tissues that perpetuates tissue hypoxia and resists standard drug therapies. Diseases such as sepsis, chronic cutaneous wounds, kidney disease, traumatic brain injury, solid tumors, inflammatory bowel disease, and chronic bacterial infections (urinary tract infection, cystic fibrosis) are tissue specific manifestations of chronic IH. Successful reversal of IH, through tissue re-oxygenation therapy (TROT), will break this vicious cycle and restore tissue homeostasis. The examples of solid tumors and inflammatory bowel disease are presented to illustrate a theoretical framework to support this hypothesis. Re-oxygenation of compromised tissues must occur before successful treatment of these diverse chronic disease s can be expected.


Asunto(s)
Enfermedad Crónica , Oxigenoterapia Hiperbárica/métodos , Hipoxia/terapia , Oxígeno/farmacocinética , Animales , Permeabilidad de la Membrana Celular , Enfermedad Crónica/terapia , Humanos , Hipoxia/complicaciones , Hipoxia/metabolismo , Inflamación/complicaciones , Inflamación/metabolismo , Inflamación/terapia , Consumo de Oxígeno/fisiología , Insuficiencia del Tratamiento
2.
Adv Exp Med Biol ; 876: 223-231, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26782216

RESUMEN

Complications following invasive medical and surgical procedures are common and costly. No clinical protocols exist to actively condition patients prior to these high risk interventions. Effective preconditioning algorithms have been repeatedly demonstrated in animal models for more than a quarter century, where brief exposures to hyperthermia (heat shock), ischemia (ischemic preconditioning) or hypoxia have been employed. Heat shock pretreatment confers protection against experimental acute ischemia-reperfusion, endotoxin challenge and other stressors. The resulting state of protection is short lived (hours) and is associated with new gene expression, typical of a cell stress response (CSR). We aim to use the CSR to actively precondition patients before surgery, a process termed stress conditioning (SC). SC is a procedure in which tissues are briefly exposed to a conditioning stressor and recovered to permit the development of a transient state of resistance to ischemia-reperfusion injury. Successful SC of humans prior to surgery may reduce postoperative complications related to periods of hypotension, hypoxia, or ischemia. Stressors such as heat shock, acute ischemia, endotoxin, heavy metals or hypoxia can induce this protected state but are themselves harmful and of limited clinical utility. The identification of a stressor that could induce the CSR in a non-harmful manner seemed unlikely, until high dose oxygen was considered. Human microvascular endothelial cells (HMEC-1) exposed to high dose oxygen at 2.4 ATA × 60-90 min developed increased resistance to an oxidant challenge in vitro (peroxide). The molecular changes described here, together with our understanding of the CSR and SC phenomena, suggest high dose oxygen may be the drug of choice for clinical preconditioning protocols and should be systematically tested in clinical trials. Oxygen dosing includes the following ranges: room air exposure is 0.21 ATA, clinical oxygen therapy 0.3-1.0 ATA (normobaric hyperoxia) and hyperbaric oxygen is 1.5-3.0 ATA (ATA-atmosphere absolute).


Asunto(s)
Oxigenoterapia Hiperbárica , Precondicionamiento Isquémico , Estrés Fisiológico , Animales , Humanos
3.
Cell Stress Chaperones ; 6(2): 164-71, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11599578

RESUMEN

Heat and a variety of other stressors cause mammalian cells and tissues to acquire cytoprotection. This transient state of altered cellular physiology is nonproliferative and antiapoptotic. In this study, male Wistar rats were stress conditioned with either stannous chloride or gallium nitrate, which have immunosuppressive effects in vivo and in vitro, or heat shock, the most intensively studied inducer of cytoprotection. The early stages of inflammation in response to topical suffusion of mesentery tissue with formyl-methionyl-leucyl-phenylalanine (FMLP) were monitored using intravital microscopy. Microvascular hemodynamics (venular diameter, red blood cell velocity [Vrbc], white blood cell [WBC] flux, and leukocyte-endothelial adhesion [LEA]) were used as indicators of inflammation, and tissue levels of inducible Hsp70, determined using immunoblot assays, provided a marker of cytoprotection. None of the experimental treatments blocked decreases in WBC flux during FMLP suffusion, an indicator of increased low-affinity interactions between leukocytes and vascular endothelium known as rolling adhesion. During FMLP suffusion LEA, an indicator of firm attachment between leukocytes and vascular endothelial cells increased in placebo and gallium nitrate-treated animals but not in heat- and stannous chloride-treated animals, an anti-inflammatory effect. Hsp70 was not detected in aortic tissue from placebo and gallium nitrate-treated animals, indicating that Hsp70-dependent cytoprotection was not present. In contrast, Hsp70 was detected in aortic tissues from heat- and stannous chloride-treated animals, indicating that these tissues were in a cytoprotected state that was also an anti-inflammatory state.


Asunto(s)
Galio/farmacología , Respuesta al Choque Térmico/inmunología , Inmunosupresores/farmacología , Inflamación/inmunología , Compuestos de Estaño/farmacología , Animales , Adhesión Celular/inmunología , Citoprotección/inmunología , Endotelio Vascular/inmunología , Endotelio Vascular/patología , Endotelio Vascular/fisiopatología , Hemodinámica/inmunología , Hemodinámica/fisiología , Calor , Hipertermia Inducida , Immunoblotting , Inflamación/patología , Inflamación/fisiopatología , Leucocitos/efectos de los fármacos , Leucocitos/inmunología , Leucocitos/efectos de la radiación , Masculino , N-Formilmetionina Leucil-Fenilalanina/metabolismo , Ratas , Ratas Wistar
4.
Transplantation ; 70(1): 205-8, 2000 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-10919602

RESUMEN

BACKGROUND: The success of organ-replacement therapies has resulted in a population of chronically immunosuppressed but active people who experience increased vulnerability to tick-borne zoonoses. Several of these infections may be life threatening. Human babesiosis is an emerging zoonosis that is transmitted by the same tick that transmits Lyme disease and human granulocytic ehrlichiosis. METHODS: We briefly review these zoonoses and present a case of a renal transplant recipient who survived infection by Babesia microti contracted through blood transfusion. RESULTS: A recipient of a living-related renal transplant developed acute postoperative hemolytic anemia. The etiology of this anemia was diagnosed by peripheral red blood cell smear as Babesia microti. The patient was managed by a reduction in transplant immunosuppressive therapy and administration of clindamycin and quinine antimicrobials. CONCLUSIONS: Transplant patients may contract babesiosis after tick exposure and/or via blood transfusion. The diagnosis of babesiosis may be confused with malaria and should be included in the differential diagnosis of posttransplant hemolytic-uremic syndrome in organ transplant patients.


Asunto(s)
Babesiosis/etiología , Trasplante de Riñón/efectos adversos , Reacción a la Transfusión , Enfermedad Aguda , Anemia Hemolítica/etiología , Animales , Femenino , Humanos , Ixodes/parasitología , Persona de Mediana Edad
5.
Cell Stress Chaperones ; 5(5): 412-4, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11189445

RESUMEN

In vitro and ex vivo tissue models provide a useful level of biological organization for cytoprotection studies positioned between cultured cells and intact animals. We have used 2 such models, primary tissue cultures of winter flounder renal secretory epithelium and ex vivo preparations of rat intestinal tissues, the latter to access the microcirculation of exposed mesentery tissues. Herein we discuss studies indicating that differentiated functions are altered in thermotolerant or cytoprotected tissues. These functions include transepithelial transport in renal epithelium and attachment and transmigration of leukocytes across vascular endothelium in response to mediators of inflammation. Evidence pointing to inflammation as a major venue for the heat shock response in vertebrates continues to mount. One such venue is wound healing. Heat shock proteins are induced early in wound responses, and some are released into the extracellular wound fluid where they appear to function as proinflammatory cytokines. However, within responding cells in the wound, heat shock proteins contribute to the acquisition of a state of cytoprotection that protects cells from the hostile environment of the wound, an environment created to destroy pathogens and essentially sterilize the wound. We propose that the cytoprotected state is an anti-inflammatory state that contributes to limiting the inflammatory response; that is, it serves as a brake on inflammation.


Asunto(s)
Citoprotección/inmunología , Trastornos de Estrés por Calor/patología , Respuesta al Choque Térmico/inmunología , Cicatrización de Heridas/inmunología , Animales , Adhesión Celular/inmunología , Cloruros/farmacocinética , Endotelio Vascular/inmunología , Endotelio Vascular/patología , Endotelio Vascular/fisiopatología , Células Epiteliales/metabolismo , Trastornos de Estrés por Calor/inmunología , Trastornos de Estrés por Calor/fisiopatología , Inflamación/inmunología , Inflamación/patología , Inflamación/fisiopatología , Riñón/metabolismo , Riñón/patología , Riñón/fisiopatología , Leucocitos/inmunología , Leucocitos/patología , N-Formilmetionina Leucil-Fenilalanina/metabolismo , Ratas , Compuestos de Zinc/farmacocinética
6.
Ann N Y Acad Sci ; 874: 320-5, 1999 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-10415543

RESUMEN

All forms of surgical therapy are stressful and injurious. The majority of surgical procedures are performed electively and provide an opportunity to condition the patient before surgery to maximize outcome. We have successfully protected the spinal cord and kidneys from warm ischemia-reperfusion injury with whole-body heat shock (42.5 degrees C, 15 min, HS) and recovery (37 degrees C, 6-8 h) before acute aortic occlusion. Control rabbits experienced an 88% incidence of paralysis (7/8) after acute spinal cord ischemia, while HS-pretreated animals never became paralyzed (0/9, p < 0.001). Control pig kidneys showed partial function (4/8 survival) after 90-min warm ischemia, while HS-pretreated kidneys always functioned (8/8 survival, p < 0.04). A positive temporal association was made between the HS-associated functional protection and the enhanced expression of inducible HSP70. The induction of the heat-shock response (cellular stress response) to protect tissues from lethal acute ischemia-reperfusion injury could be employed in a wide range of medical and surgical settings.


Asunto(s)
Condicionamiento Psicológico/fisiología , Respuesta al Choque Térmico/fisiología , Complicaciones Posoperatorias/fisiopatología , Estrés Fisiológico/fisiopatología , Animales , Isquemia/fisiopatología , Isquemia/prevención & control , Conejos , Circulación Renal/fisiología , Daño por Reperfusión/prevención & control , Médula Espinal/irrigación sanguínea , Porcinos
10.
Conn Med ; 60(7): 387-93, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8758656

RESUMEN

Over 1,243 organ transplants have been performed at the Hartford Transplant Center over the past two decades. Survival in kidney, heart, liver, and pancreas patients is at or above the national average. Hartford was one of the first centers to use triple immunosuppression, which significantly improved survival in kidney transplantation. For recipients of kidneys from living related donors and cadaveric kidneys, two-year actuarial graft survival has been 98% and 83%, respectively, over the last five years. For heart and liver transplants, two-year survival has been 79% and 67%, respectively. Despite high success rates at most transplant centers, donor organs remain scarce. This problem needs to be addressed through increased cooperative efforts in the health-care community and the general public.


Asunto(s)
Trasplante de Órganos , Adolescente , Adulto , Anciano , Niño , Preescolar , Connecticut , Estudios de Evaluación como Asunto , Supervivencia de Injerto , Trasplante de Corazón/estadística & datos numéricos , Humanos , Trasplante de Riñón/estadística & datos numéricos , Trasplante de Hígado/estadística & datos numéricos , Persona de Mediana Edad , Trasplante de Órganos/estadística & datos numéricos , Trasplante de Páncreas/estadística & datos numéricos
11.
Transplant Proc ; 27(6): 3400-2, 1995 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8540018

RESUMEN

1. BSA-containing solutions improve islet yields using standard collagenase digestion techniques. 2. The BSA effect on islet isolation is independent of source and lot of collagenase. 3. The BSA effect on islet isolation is not due solely to its colloid action, as HES failed to achieve the same level of improvement seen with albumin. 4. BSA can protect islets from warm ischemic injury, and the protective action appears to be unique to albumin, as HES was not as effective.


Asunto(s)
Separación Celular/métodos , Islotes Pancreáticos/citología , Albúmina Sérica Bovina , Animales , Colagenasas , Coloides , Estudios de Evaluación como Asunto , Técnicas In Vitro , Isquemia/prevención & control , Islotes Pancreáticos/irrigación sanguínea , Islotes Pancreáticos/lesiones , Trasplante de Islotes Pancreáticos , Soluciones Isotónicas , Ratas , Ratas Endogámicas Lew
12.
New Horiz ; 3(2): 312-20, 1995 May.
Artículo en Inglés | MEDLINE | ID: mdl-7583172

RESUMEN

Tissue injury, resulting from ischemia and reperfusion, is a common theme seen in many clinical disease processes. Conditions ranging from hemorrhagic shock in the young trauma victim to myocardial infarction in the elderly have, as part of their pathophysiology, some degree of ischemia and reperfusion. The conditions typical of modern organ preservation are extremely stressful and injurious to living tissues. Organ preservation is a model of ischemia and reperfusion unique to the medical field as it permits the opportunity for preventive interventions. The established fields of thermotolerance and heat-shock biology have focused their studies upon the understanding of the cellular response to hyperthermia. The knowledge gained from these two disciplines shows that the cellular response to heat is an example of a more generalized stress response. Following the acute heat-shock response, the cell rapidly acquires a state of temporary protection against injury due to heat and other noxious conditions such as ischemia and reperfusion. The studies described here illustrate that the purposeful induction of the heat-shock response in whole organs prior to procurement and preservation can successfully protect these tissues against preservation (ischemia) and transplantation (reperfusion) injuries.


Asunto(s)
Proteínas de Choque Térmico/fisiología , Calor , Estrés Fisiológico/fisiopatología , Animales , Humanos , Isquemia/fisiopatología , Preservación de Órganos , Ratas , Daño por Reperfusión/prevención & control , Porcinos
13.
Clin Transplant ; 9(1): 45-52, 1995 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-7537988

RESUMEN

Although initial experiences with FK 506 rescue therapy for acute hepatic allograft rejection have provided promising results, analysis of available data indicates that inferior results are obtained when FK 506 rescue therapy is initiated in the latter stages of rejection. Since its initial availability, we have applied an aggressive approach towards FK 506 rescue therapy based on early conversion and assiduous dosing. We have reviewed our experience with this approach in patients with refractory hepatic allograft rejection to provide an assessment of this approach. Sixteen patients were treated for corticosteroid and OKT3-resistant acute hepatic allograft rejection. Fourteen patients were treated for cellular rejection and 2 for humorally-mediated rejection. Median follow-up was 7.3 months posttransplant and 6.0 months post-initiation of FK 506 therapy. Median time to first rejection was 8 days and median time to FK 506 therapy was 29 days. Laboratory values at the time of initiation of FK 506 therapy included: mean serum bilirubin, 4.0 +/- 3.1 mg/dl and SGPT 136 +/- 105 U/l. Prior to FK 506 therapy, patients received an average of 35.5 +/- 19.1 mg/kg of bolus/taper corticosteroids (prednisone equivalent) and 11.25 +/- 4.8 days of OKT3 therapy. FK 506 therapy was successful in reversing all episodes of rejection. Median time to rejection reversal with FK 506 rescue therapy was 23 days (mean +/- SD, 27.6 +/- 16.7 days) in patients with cellular rejection. Time to rejection reversal was 26 and 28 days in the 2 patients with humoral rejection. Patient and graft survival at 6 months were 100%/100%, and 94%/94% at 12 months.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Rechazo de Injerto/tratamiento farmacológico , Trasplante de Hígado/inmunología , Tacrolimus/uso terapéutico , Adulto , Azatioprina/uso terapéutico , Ciclosporina/uso terapéutico , Infecciones por Citomegalovirus/epidemiología , Femenino , Estudios de Seguimiento , Rechazo de Injerto/prevención & control , Supervivencia de Injerto , Humanos , Terapia de Inmunosupresión , Masculino , Hemisuccinato de Metilprednisolona/uso terapéutico , Persona de Mediana Edad , Muromonab-CD3/uso terapéutico , Factores de Riesgo , Tacrolimus/administración & dosificación , Factores de Tiempo
20.
Surgery ; 113(3): 344-51, 1993 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8441970

RESUMEN

Refractory esophageal variceal hemorrhage (EVH) remains a formidable problem in patients awaiting liver transplantations. Transjugular intrahepatic portosystemic shunts (TIPS) have provided an alternative approach for managing EVH that may obviate the need for portosystemic shunt surgery. Experience with TIPS placement and subsequent successful hepatic transplantation in patients without previous portosystemic shunt surgery has not been previously reported. Two patients are reported who underwent TIPS placement and subsequent successful hepatic transplantation without previous portosystemic shunt surgery. This experience indicates that (1) TIPS can provide effective control of EVH for at least several weeks, (2) TIPS placement decreases portal hypertension, thus facilitating technical performance of the transplant procedure and minimizing blood loss, (3) TIPS may undergo vascular incorporation, thus requiring that they be accurately positioned so that the lengths of suprahepatic inferior vena cava and portal vein are not compromised at the time of transplantation, (4) TIPS thrombosis can be effectively treated and prolonged patency may be observed, and (5) deterioration in hepatic function and exacerbation of hepatic encephalopathy were not observed after TIPS placement. In summary, TIPS provide an attractive, effective means for managing refractory EVH in patients awaiting liver transplantation.


Asunto(s)
Hemorragia Gastrointestinal/terapia , Derivación Portosistémica Quirúrgica/instrumentación , Stents , Várices Esofágicas y Gástricas/complicaciones , Femenino , Hemorragia Gastrointestinal/etiología , Humanos , Trasplante de Hígado , Persona de Mediana Edad , Grado de Desobstrucción Vascular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA